aTyr Pharma to Participate in ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28thGlobeNewsWire • 10/27/20
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in JapanGlobeNewsWire • 09/15/20
aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLCGlobeNewsWire • 09/14/20
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/14/20
aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial ProgramsGlobeNewsWire • 08/13/20
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in JapanGlobeNewsWire • 08/11/20
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial ResultsGlobeNewsWire • 08/06/20
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 08/05/20
aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting IIGlobeNewsWire • 06/22/20
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 InfectionGlobeNewsWire • 06/17/20
aTyr Pharma Announces Dosing of First Patient in Phase 2 Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory ComplicationsGlobeNewsWire • 06/15/20
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20
aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19GlobeNewsWire • 05/12/20
aTyr Pharma Announces Publication of Two Abstracts in American Journal of Respiratory and Critical Care MedicineGlobeNewsWire • 05/05/20
aTyr Pharma Announces Phase 2 Study of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications Following FDA Acceptance of IND ApplicationGlobeNewsWire • 04/21/20
Atyr Pharma (LIFE) Reports Q4 Loss, Beats Revenue Estimates (Revised)Zacks Investment Research • 03/27/20
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/27/20